Free tool
Drugs in development
Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations
Drugs in development
3,685
Not FDA-approved
In Phase 3
1,424
Highest phase reached
Matching your filters
52
52 drugs in development
Names, sponsors and conditions come from the trial records. Click a drug for its trials.
- GiredestrantRO7197597, GDC-9545Phase 316 trials
Roche (Genentech) · Early Breast Cancer, Breast Cancer, Estrogen Receptor (ER)-Positive, HER2-negative, Locally Advanced or Metastatic Breast Cancer
- AfimkibartRO7790121, RVT-3101Phase 312 trials
Roche (Genentech) · Moderately to Severely Active Ulcerative Colitis, Moderately to Severely Active Crohns Disease, Atopic Dermatitis
- TiragolumabMTIG7192A, RO7092284Phase 311 trials
Roche (Genentech) · Hepatocellular Carcinoma, Rectal Neoplasms, Rectal Cancer
- AtirmociclibPF-07220060Phase 39 trials
Pfizer · Breast Cancer, Advanced Breast Cancer, Metastatic Breast Cancer
- DivarasibGDC-6036, RO7435846Phase 38 trials
Roche (Genentech) · Non-Small Cell Lung Cancer, KRAS G12C Lung Cancer, Non-small Cell Lung Cancer
- FenebrutinibRO7010939, GDC-0853Phase 36 trials
Roche (Genentech) · Relapsing Multiple Sclerosis, Multiple Sclerosis, Multiple Sclerosis, Primary Progressive
- LHRH AgonistPhase 36 trials
Roche (Genentech) · Estrogen Receptor (ER)-Positive, HER2-negative, Locally Advanced or Metastatic Breast Cancer, Early Breast Cancer, Estrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer
- IpatasertibRO5532961, GDC-0068Phase 35 trials
Roche (Genentech) · Metastatic Breast Cancer, Inoperable, Locally Advanced or Metastatic, ER-positive Breast Cancer, Ovarian Cancer
- rHuPH20Phase 35 trials
Bristol Myers Squibb · Melanoma, Relapsing-remitting Multiple Sclerosis, Clear Cell Renal Cell Carcinoma
- CevostamabRO7187797Phase 34 trials
Roche (Genentech) · Multiple Myeloma
- TrontinemabRO7126209, RG6102Phase 34 trials
Roche (Genentech) · Alzheimers Disease, Alzheimer's Disease
- AstegolimabPhase 33 trials
Roche (Genentech) · Chronic Obstructive Pulmonary Disease, Chronic Obstructive Pulmonary Disease (COPD)
- bypassing agentsClotting factor concentrates, CFCPhase 33 trials
Sanofi · Hemophilia, Von Willebrand Disease, Type 3
- LHRHLuteinizing hormone-releasing hormone agonist, Luteinizing Hormone-Releasing Hormone AgonistsPhase 33 trials
AstraZeneca · ER-Positive HER2-Negative Breast Cancer, Ovarian Cancer
- PegozaferminBIO89-100Phase 33 trials
Roche (Genentech) · Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated Cirrhosis, Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH) With Fibrosis, Severe Hypertriglyceridemia
- PrasinezumabRO7046015, PRX002Phase 33 trials
Roche (Genentech) · Parkinson's Disease, Parkinsons Disease
- RO7204239Phase 33 trials
Roche (Genentech) · Obesity, Overweight, Overweight With One Weight Related Comorbidity
- BL-8040Phase 32 trials
BioLineRx, Ltd. · Multiple Myeloma, Pancreatic Adenocarcinoma
- CDK4Phase 32 trials
Qilu Pharmaceutical Co., Ltd. · Advanced ER+/HER2- Breast Cancer, Breast Cancer
- EmactuzumabPhase 32 trials
Roche (Genentech) · Cancer, TGCT
- NXT007Zemocimig, RO7589655Phase 32 trials
Roche (Genentech) · Hemophilia A
- RituxumabPhase 32 trials
Roche (Genentech) · Diffuse Large B-cell Lymphoma, DLBCL - Diffuse Large B Cell Lymphoma
- TPST-1120Phase 32 trials
Roche (Genentech) · Advanced Liver Cancers, Hepatocellular Carcinoma (HCC)
- VamikibartRO7200220Phase 32 trials
Roche (Genentech) · Uveitic Macular Edema
- ZN-A-1041ZN-A-1041 Enteric, RO7771950Phase 32 trials
Roche (Genentech) · HER2-positive Breast Cancer, Advanced Solid Tumors
- BecavizumabPhase 31 trial
Roche (Genentech) · Hepatocellular Carcinoma
- Fixed of PertuzumabPhase 31 trial
Roche (Genentech) · Early Breast Cancer, Locally Advanced Breast Cancer, Inflammatory Breast Cancer
- Intravitreal RanibizumabPhase 31 trial
Roche (Genentech) · Diabetic Macular Edema
- SefaxersenRO7434656Phase 31 trial
Roche (Genentech) · Primary IgA Nephropathy
- TociluzumabPhase 31 trial
Roche (Genentech) · Relapsed or Refractory Follicular Lymphoma
- RO7247669Tobemstomig, RG6139Phase 26 trials
Roche (Genentech) · Solid Tumors, Metastatic Melanoma, Non-small Cell Lung Cancer
- AB928Etrumadenant, ETRUMAPhase 24 trials
Arcus Biosciences, Inc. · Lung Cancer, Advanced or Metastatic Non-Small-Cell Lung Cancer, Resectable Non-Small-Cell Lung Cancer
- RO7198457Autogene CevumeranPhase 24 trials
Roche (Genentech) · Colorectal Cancer Stage II, Colorectal Cancer Stage III, Adenocarcinoma, Pancreatic Ductal
- ADG126Phase 23 trials
Adagene Inc · Advanced/Metastatic Solid Tumors, Solid Tumor, Advanced Liver Cancers
- SamuraciclibICEC0942, CT7001Phase 23 trials
Carrick Therapeutics Limited · Metastatic Breast Cancer, Locally Advanced Breast Cancer, Breast Cancer
- BelvarafenibHM95573Phase 22 trials
Hanmi Pharmaceutical Company Limited · Advanced or Metastatic Melanoma, Solid Tumors
- CamonsertibRP-3500Phase 22 trials
Roche (Genentech) · Solid Tumors, Advanced Solid Tumor
- OpRegenPhase 22 trials
Roche (Genentech) · Age-Related Macular Degeneration, Geographic Atrophy
- RO7568282Phase 22 trials
Roche (Genentech) · Parkinson's Disease, Alzheimer's Disease
- SelicrelumabPhase 22 trials
Roche (Genentech) · Metastatic Breast Cancer, Pancreatic Adenocarcinoma
- TifeglipronRO7795081, CT-996Phase 22 trials
Roche (Genentech) · Type 2 Diabetes Mellitus, Obesity or Overweight
- IO-108Phase 21 trial
Roche (Genentech) · Advanced Liver Cancers
- NKT2152Phase 21 trial
Roche (Genentech) · Advanced Liver Cancers
- PEGPH20Phase 21 trial
Roche (Genentech) · Pancreatic Adenocarcinoma
- RO0091978Phase 21 trial
Roche (Genentech) · Metastatic Breast Cancer
- RO6874281Phase 21 trial
Roche (Genentech) · Pancreatic Adenocarcinoma
- RO7268489Phase 21 trial
Roche (Genentech) · Progressive Multiple Sclerosis
- RO7269162Phase 21 trial
Roche (Genentech) · Alzheimer's Disease
- RO7275887Phase 21 trial
Roche (Genentech) · Chronic Obstructive Pulmonary Disease (COPD), Healthy Participants
- RO7830698Phase 21 trial
Roche (Genentech) · Chronic Obstructive Pulmonary Disease (COPD), Healthy Participants
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.